Get the Stockscreener App
4.43
1.84%
0.08
After Hours:
4.41
-0.02
-0.45%
Atai Beckley N V stock is traded at $4.43, with a volume of 3.76M.
It is up +1.84% in the last 24 hours and down -13.14% over the past month.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
See More
Previous Close:
$4.35
Open:
$4.31
24h Volume:
3.76M
Relative Volume:
0.62
Market Cap:
$949.52M
Revenue:
$2.59M
Net Income/Loss:
$-137.89M
P/E Ratio:
-5.4691
EPS:
-0.81
Net Cash Flow:
$-69.76M
1W Performance:
-16.10%
1M Performance:
-13.14%
6M Performance:
+218.71%
1Y Performance:
+180.38%
1-Day Range:
$4.24
$4.56
1-Week Range:
$4.14
$5.22
52-Week Range:
$1.15
$6.75
Atai Beckley N V Stock (ATAI) Company Profile
Name
Atai Beckley N V
Sector
Industry
Phone
49 89 2153 9035
Address
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Compare ATAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATAI
Atai Beckley N V
|
4.43 | 1.58B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.22 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
674.55 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.95 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
889.64 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.69 | 40.93B | 447.02M | -1.18B | -906.14M | -6.1812 |
Atai Beckley N V Stock (ATAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Initiated | Needham | Buy |
| Jul-29-25 | Initiated | Oppenheimer | Outperform |
| Nov-18-24 | Reiterated | H.C. Wainwright | Buy |
| Apr-03-24 | Upgrade | Maxim Group | Hold → Buy |
| Nov-01-22 | Initiated | Loop Capital | Buy |
| Nov-30-21 | Initiated | Maxim Group | Buy |
| Nov-11-21 | Initiated | ROTH Capital | Buy |
| Oct-18-21 | Initiated | H.C. Wainwright | Buy |
| Sep-01-21 | Initiated | Jefferies | Buy |
| Jul-13-21 | Initiated | Berenberg | Buy |
| Jul-13-21 | Initiated | Canaccord Genuity | Buy |
| Jul-13-21 | Initiated | Cantor Fitzgerald | Buy |
| Jul-13-21 | Initiated | Citigroup | Buy |
| Jul-13-21 | Initiated | Cowen | Outperform |
| Jul-13-21 | Initiated | Credit Suisse | Outperform |
| Jul-13-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-08-21 | Initiated | Aegis Capital | Buy |
View All
Atai Beckley N V Stock (ATAI) Latest News
Atai Beckley Reports Positive Phase 2b Extension Data for Depression Treatment - MarketScreener
Why Atai Life Sciences N.V. (9VC) stock stays undervalued2025 Earnings Impact & Precise Swing Trade Alerts - newser.com
Why Atai Life Sciences N.V. (9VC) stock appears on watchlistsPortfolio Performance Report & Low Drawdown Investment Strategies - newser.com
AtaiBeckley Announces Positive Topline Data from the Phase - GlobeNewswire
Why Atai Life Sciences N.V. (9VC) stock is trending on social media2025 EndofYear Setup & Intraday High Probability Alerts - newser.com
Will Atai Life Sciences N.V. (9VC) stock justify high valuationWeekly Gains Report & Fast Exit Strategy with Risk Control - newser.com
Is Atai Life Sciences N.V. stock poised for growth2025 Earnings Impact & Weekly Market Pulse Updates - newser.com
Is Atai Life Sciences N.V. (9VC) stock nearing a technical breakoutJuly 2025 Macro Moves & Daily Growth Stock Tips - newser.com
Will Atai Life Sciences N.V. stock reach all time highs in 2025Trade Ideas & Safe Capital Preservation Plans - newser.com
Published on: 2025-11-08 08:57:18 - newser.com
Is Atai Life Sciences N.V. (9VC) stock trading at attractive multiplesPortfolio Value Report & Stock Portfolio Risk Control - newser.com
ATAI Life Sciences Files Prospectus for Share Resale - MSN
Will Atai Life Sciences N.V. stock sustain high P E ratios2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com
Combining machine learning predictions for Atai Life Sciences N.V.2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com
Building trade automation scripts for Atai Life Sciences N.V.July 2025 Summary & Daily Price Action Insights - newser.com
Can Atai Life Sciences N.V. stock resist sector downturnsWeekly Earnings Recap & Expert Approved Trade Ideas - newser.com
Why Atai Life Sciences N.V. stock appeals to dividend seekers2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
Will Atai Life Sciences N.V. stock benefit from upcoming earnings reportsJuly 2025 Breakouts & Community Driven Trade Alerts - Fundação Cultural do Pará
Is Atai Life Sciences N.V. stock a defensive play in 2025Inflation Watch & Real-Time Buy Signal Alerts - newser.com
Chart based analysis of Atai Life Sciences N.V. trendsJuly 2025 Chart Watch & Daily Market Momentum Tracking - newser.com
Latham & Watkins Advises atai Life Sciences in Strategic Combination With Beckley Psytech to Form AtaiBeckley - Legal Desire Media and Insights
Will Atai Life Sciences N.V. (9VC) stock test record highs in 2025Exit Point & AI Driven Price Predictions - newser.com
Atai Beckley files prospectus supplement for resale of 5.3 million shares By Investing.com - Investing.com Nigeria
Understanding Atai Life Sciences N.V.’s price movementQuarterly Market Review & Precise Trade Entry Recommendations - newser.com
Is Atai Life Sciences N.V. stock recession proofJuly 2025 Update & Accurate Intraday Trade Tips - fcp.pa.gov.br
Atai Life Sciences N.V. (ATAI) Stock: Sharp Drop Follows Bold Merger Creating AtaiBeckley Biopharma Powerhouse - parameter.io
Why Atai Life Sciences N.V. (9VC) stock could break out in 2025Trade Entry Report & Accurate Intraday Trading Signals - Fundação Cultural do Pará
Atai Beckley files prospectus supplement for resale of 5.3 million shares - Investing.com Australia
atai Life Sciences and Beckley Psytech complete strategic combination to form AtaiBeckley - Proactive financial news
Form 424B7 ATAI Life Sciences N.V. - StreetInsider
ATAI Life Sciences Completes Acquisition of Beckley Psytech - TipRanks
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies - The Manila Times
Atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies - MarketScreener
AtaiBeckley (NASDAQ: ATAI) finalizes all-share deal; funding expected into 2029 - Stock Titan
Atai Life Sciences N.V. stock trend forecastJuly 2025 Macro Moves & Long-Term Growth Stock Strategies - newser.com
Will Atai Life Sciences N.V. (9VC) stock outperform energy sector in 2025July 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Why analysts recommend Atai Life Sciences N.V. (9VC) stockWeekly Risk Report & Consistent Income Trade Ideas - newser.com
ATAI Life Sciences shareholders approve acquisition of Beckley Psytech and redomiciliation - Investing.com
United States Psychedelic Drugs Market 2025: Industry - openPR.com
How analysts rate Atai Life Sciences N.V. stock todayBreakout Watch & Smart Money Movement Alerts - Fundação Cultural do Pará
Atai Beckley N V Stock (ATAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):